CLINICAL_TRIALS
research
· 2025-12-04
Clinical Trial Update: AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy
Summary
An ongoing study sponsored by Zhejiang University aims to develop AI-based methods for diagnosing and forecasting outcomes in hypertrophic cardiomyopathy and as…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Hypertrophic Cardiomyopathy (HCM), Left Ventricular Hypertrophy | Status: RECRUITING